sixty per cent ( 53 of 87 ) patients were p24 viral antigen positive at the start of treatment and 19 % of them had a fall of more than 50 % in antigen level in three months while 32 % became antigen negative within 2.5 months .
C0003342
viral
C0003320
antigen